Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Bruce I Sachs. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Bruce I Sachs har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:VRTX / Vertex Pharmaceuticals Incorporated Director 45.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Bruce I Sachs. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Bruce I Sachs som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 3.366 45.000 8,08 389,84 1.312.201 17.542.800
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 1.634 41.634 4,08 389,36 636.214 16.210.614
2024-08-02 2024-08-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.295 40.000 -11,69 508,00 -2.689.860 20.320.000
2024-08-02 2024-08-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.295 45.295 13,24 125,71 665.634 5.694.034
2024-05-24 2024-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.073 40.000 -15,03 448,00 -3.168.704 17.920.000
2024-05-24 2024-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.073 47.073 17,68 93,51 661.396 4.401.796
2023-11-08 2023-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.250 40.000 -21,95 385,00 -4.331.250 15.400.000
2023-11-08 2023-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11.250 51.250 28,12 127,54 1.434.825 6.536.425
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.842 40.000 -8,76 357,29 -1.372.708 14.291.600
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.711 43.842 -11,53 356,75 -2.037.399 15.640.634
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.697 49.553 -3,31 355,54 -603.351 17.618.074
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11.250 51.250 28,12 127,54 1.434.825 6.536.425
2023-04-14 2023-04-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -1.210 40.000 -2,94
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -8.026 41.210 -16,30 327,48 -2.628.354 13.495.451
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.357 49.236 -17,38 326,46 -3.381.146 16.073.585
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.917 59.593 -4,67 325,65 -949.921 19.406.460
2023-04-14 2023-04-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 21.300 62.510 51,69 72,14 1.536.582 4.509.471
2023-02-02 2023-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 41.210 -2,83 325,01 -390.012 13.393.662
2023-02-02 2023-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.200 42.410 2,91 72,14 86.568 3.059.457
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4.462 4.462
2022-04-18 2022-04-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 151 13.824 1,11 289,41 43.750 4.000.661
2022-01-19 2022-01-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 190 13.672 1,41 230,58 43.750 3.152.568
2021-10-18 2021-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 240 13.483 1,81 182,07 43.750 2.454.777
2021-08-04 2021-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 15.000 41.210 57,23 197,91 2.968.650 8.155.871
2021-07-16 2021-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 221 13.242 1,70 198,00 43.750 2.621.977
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6.067 6.067
2021-04-16 2021-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 199 13.021 1,55 220,17 43.750 2.866.910
2021-01-19 2021-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 194 12.823 1,53 225,99 43.750 2.897.787
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 3.905 26.210 17,51 218,79 854.375 5.734.486
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4.270 22.305 23,68 217,49 928.682 4.851.114
2020-11-12 2020-11-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 6.825 18.035 60,88 216,47 1.477.408 3.904.036
2020-10-19 2020-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 196 12.629 1,58 222,81 43.750 2.813.877
2020-07-17 2020-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 155 12.433 1,26 292,77 45.453 3.639.917
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4.527 4.527
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -22.500 0 -100,00
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -22.500 0 -100,00
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.960 11.210 -20,89 272,46 -806.482 3.054.277
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.232 14.170 -30,55 271,63 -1.692.798 3.848.997
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.889 20.402 -22,40 270,49 -1.592.916 5.518.537
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.751 26.291 -37,46 269,53 -4.245.367 7.086.213
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.568 42.042 -21,58 268,65 -3.107.743 11.294.583
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.600 53.610 -4,63 267,50 -695.500 14.340.675
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 22.500 56.210 66,75 81,54 1.834.650 4.583.363
2020-05-08 2020-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 22.500 33.710 200,71 59,55 1.339.875 2.007.430
2020-04-17 2020-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 179 12.277 1,48 258,56 46.250 3.174.453
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 11.210 -0,88 235,40 -23.540 2.638.834
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -900 11.310 -7,37 234,15 -210.735 2.648.236
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.800 12.210 -12,85 233,13 -419.634 2.846.517
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 14.010 -7,89 232,04 -278.448 3.250.880
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 15.210 -7,31 230,87 -277.044 3.511.533
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 16.410 -2,96 229,90 -114.950 3.772.659
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 16.910 -3,43 228,33 -136.998 3.861.060
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 17.510 -1,68 227,66 -68.298 3.986.327
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.644 17.810 -24,06 227,01 -1.281.244 4.043.048
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.198 23.454 -15,18 226,32 -950.091 5.308.109
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.858 27.652 -6,30 224,98 -418.013 6.221.147
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.700 29.510 -5,45 224,02 -380.834 6.610.830
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20.000 31.210 178,41 53,85 1.077.000 1.680.658
2020-01-17 2020-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 200 12.099 1,68 231,55 46.250 2.801.421
2019-10-17 2019-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 264 11.899 2,26 175,50 46.250 2.088.242
2019-07-17 2019-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 257 11.635 2,26 176,39 45.371 2.052.348
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 1.801 11.378 18,81
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6.659 6.659
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -1.801 11.210 -13,84
2019-04-17 2019-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 247 9.577 2,65 182,28 45.000 1.745.707
2019-01-16 2019-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 243 9.330 2,68 184,90 45.000 1.725.152
2019-01-02 2018-12-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -10.000 13.011 -43,46
2018-12-07 2018-12-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10.000 0 -100,00
2018-12-07 2018-12-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 23.011 76,86 34,24 342.400 787.897
2018-10-17 2018-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 251 9.087 2,84 179,29 45.000 1.629.175
2018-07-18 2018-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 249 8.836 2,90 180,97 45.000 1.599.019
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2.188 8.587 34,19
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3.229 3.229
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -2.188 13.011 -14,40
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 1.801 15.199 13,44
2018-04-18 2018-04-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 280 6.399 4,57 160,89 45.000 1.029.561
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 262 6.119 4,47 157,50 41.250 963.816
2018-01-17 2017-12-20 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -10.000 13.398 -42,74
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 265 5.858 4,75 155,44 41.250 910.500
2017-07-19 2017-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 317 5.592 6,01 130,15 41.250 727.823
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2.941 5.275 125,99
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 5.295 5.295
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -2.941 23.398 -11,17
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2.188 26.339 9,06
2017-04-19 2017-04-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 360 2.334 18,24 114,58 41.250 267.458
2017-01-19 2017-01-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 508 1.974 34,67 81,16 41.250 160.229
2016-10-19 2016-10-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 516 1.466 54,25 80,01 41.250 117.293
2016-07-19 2016-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 461 950 94,25 89,45 41.250 85.015
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 7.073 7.073
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2.941 24.151 13,87 0,01 29 242
2016-04-19 2016-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 489 489 87,60 42.860 42.860
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 21.210 -32,04 140,13 -1.401.300 2.972.157
2015-08-05 2015-08-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 34,24 342.400 1.068.630
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22.500 22.500
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.375 21.210 -6,09 136,14 -187.192 2.887.529
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -8.625 22.585 -27,64 135,42 -1.167.998 3.058.461
2015-03-24 2015-03-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 29,89 298.900 932.867
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 21.210 -32,04 130,13 -1.301.300 2.760.057
2015-03-20 2015-03-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 29,89 298.900 932.867
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -139 0 -100,00
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -139 21.210 -0,65 125,00 -17.375 2.651.250
2015-01-22 2015-01-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 139 21.349 0,66 28,40 3.948 606.312
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -9.861 139 -98,61
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9.861 21.210 -31,74 125,04 -1.233.019 2.652.098
2015-01-13 2015-01-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9.861 31.071 46,49 28,40 280.052 882.416
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 21.210 -32,04 120,03 -1.200.300 2.545.836
2014-12-01 2014-11-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 28,40 284.000 886.364
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -9.900 0 -100,00
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9.900 21.210 -31,82 115,21 -1.140.579 2.443.604
2014-11-07 2014-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9.900 31.110 46,68 29,84 295.416 928.322
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -100 9.900 -1,00
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 21.210 -0,47 111,86 -11.186 2.372.551
2014-11-05 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 100 21.310 0,47 29,84 2.984 635.890
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 21.210 -0,47 115,45 -11.545 2.448.694
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.400 21.310 -17,11 114,23 -502.612 2.434.241
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.200 25.710 -11,07 113,47 -363.104 2.917.314
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.300 28.910 -7,37 112,47 -258.681 3.251.508
2014-11-05 2014-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 31.210 47,15 29,84 298.400 931.306
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.684 21.210 -11,23 112,80 -302.755 2.392.488
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -17.316 23.894 -42,02 112,03 -1.939.911 2.676.845
2014-11-05 2014-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20.000 41.210 94,30 34,32 686.400 1.414.327
2014-06-03 2014-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22.500 22.500
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 21.210 -2,30 76,57 -38.285 1.624.050
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.000 21.710 -12,14 75,25 -225.750 1.633.678
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.750 24.710 -10,01 74,47 -204.792 1.840.154
2014-03-25 2014-03-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.450 27.460 -8,19 73,53 -180.148 2.019.134
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.200 29.910 -9,66 84,13 -269.216 2.516.328
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.800 33.110 -10,30 83,65 -317.870 2.769.652
2014-02-24 2014-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.300 36.910 -3,40 82,51 -107.263 3.045.444
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 38.210 -1,04 86,91 -34.764 3.320.831
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.500 38.610 -3,74 85,87 -128.805 3.315.441
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 40.110 -1,47 84,90 -50.940 3.405.339
2014-01-23 2014-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.800 40.710 -12,47 83,89 -486.562 3.415.162
2013-12-26 2013-12-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 46.510 -2,52 73,45 -88.140 3.416.160
2013-12-26 2013-12-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.100 47.710 -12,95 72,95 -517.945 3.480.444
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 54.810 -0,36 67,15 -13.430 3.680.492
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.700 55.010 -3,00 66,25 -112.625 3.644.412
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.900 56.710 -7,95 65,35 -320.215 3.705.998
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -800 61.610 -1,28 64,21 -51.368 3.955.978
2013-11-21 2013-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -700 62.410 -1,11 63,10 -44.170 3.938.071
2013-10-25 2013-10-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.800 63.110 -8,42 77,17 -447.586 4.870.199
2013-10-25 2013-10-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.500 68.910 -3,50 76,80 -192.000 5.292.288
2013-09-26 2013-09-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.500 71.410 -3,38 75,23 -188.075 5.372.174
2013-09-26 2013-09-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.800 73.910 -7,28 74,86 -434.188 5.532.903
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 79.710 -0,75 77,97 -46.782 6.214.989
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.010 80.310 -6,96 77,29 -464.513 6.207.160
2013-09-03 2013-08-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.690 86.320 -1,92 76,55 -129.370 6.607.796
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 88.010 -0,68 87,03 -52.218 7.659.510
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.700 88.610 -2,96 85,89 -231.903 7.610.713
2013-07-26 2013-07-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.000 91.310 -5,19 85,10 -425.500 7.770.481
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.700 96.310 -2,73 76,53 -206.631 7.370.604
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.500 99.010 -4,35 75,85 -341.325 7.509.908
2013-06-24 2013-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.100 103.510 -1,05 74,81 -82.291 7.743.583
2013-06-04 2013-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22.500 22.500
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.262 104.610 -3,91 80,63 -343.645 8.434.704
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.538 108.872 -1,39 79,50 -122.271 8.655.324
2013-05-23 2013-05-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.500 110.410 -2,21 78,48 -196.200 8.664.977
2013-05-16 2013-05-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale -60.000 112.910 -34,70 81,15 -4.869.000 9.162.646
2013-05-08 2013-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.000 172.910 -3,89 77,41 -541.870 13.384.963
2013-05-08 2013-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.300 179.910 -0,72 76,19 -99.047 13.707.343
2012-06-01 2012-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 22.500 22.500
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)